Space startup Varda raises $187 million in funding to make drugs in orbit

Space startup Varda raises 7 million in funding to make drugs in orbit


Pavlo Gonchar | Lightrocket | Getty Images

Space startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital firms Natural Capital and Shrug Capital, to continue advancing drug manufacturing in space.

The latest round included participation from Peter Thiel, Lux Capital, Khosla Ventures and Caffeinated Capital. It brought the total capital Varda’s raised to $329 million.

“By expanding, we can support work on more complex molecules and ultimately increase cadence to achieve the turnaround times the pharmaceutical industry expects,” Chief Science Officer Adrian Radocea said in a press release Thursday.

Varda’s main mission is to launch and return drugs made in space. The startup has said the medicines crystallize differently in orbit due to the gravity differences, which would allow it to complete drugs that are currently difficult to manufacture.

In 2024, the space startup’s W-Series 1 capsule received FAA approval to return after successfully creating the drug Ritonavir the previous year.

So far, Varda said the company has been able to complete three space launches. Now, a fourth is in orbit, and the company expects to launch a fifth by the end of the year. Varda’s system uses Rocket Lab’s Photon spacecraft for its operation and adds its manufacturing module and a heatshield-protected capsule.

“With this capital, Varda will continue to increase our flight cadence and build out the pharmaceutical lab that will deliver the world’s first microgravity-enabled drug formulation,” said Varda CEO Will Bruey.

Varda Space Industries is the first company to process materials outside the International Space Station.

Recently, the space company has also operated a testbed for the U.S. government to use the W-series reentry vehicles to advance technology.

Varda said it has expanded into Huntsville, Alaska, and opened a laboratory in El Segundo, California, to begin work to crystallize more drugs.

“Our new lab space is an investment in our belief that in-space pharmaceutical manufacturing will drive the foundation of the orbital economy,” Radocea said.



Source

Starbucks to form joint venture with Boyu Capital to run China business
Business

Starbucks to form joint venture with Boyu Capital to run China business

A Starbucks outlet in Hangzhou in east China’s Zhejiang province Thursday, Oct. 30, 2025. Long Wei | Feature China | Future Publishing | Getty Images Starbucks on Monday announced it is forming a joint venture with Boyu Capital to operate the company’s locations in China. Under the terms of the deal, Boyu, an alternative asset […]

Read More
Third-quarter earnings are indicating a divided economy
Business

Third-quarter earnings are indicating a divided economy

A Taco Bell restaurant in El Cerrito, California, US, on Tuesday, April 29, 2025. David Paul Morris | Bloomberg | Getty Images With more consumer companies preparing to report third-quarter earnings this week, Wall Street will be watching for signs of a bifurcated or “K-shaped” economy as consumers diverge in their spending behaviors. There have […]

Read More
Ford, Hyundai report large declines in October EV sales after end of federal credits
Business

Ford, Hyundai report large declines in October EV sales after end of federal credits

Ford Mustang Mach-E EV vehicles at a Ford dealership in Los Angeles, California, US, on Thursday, Oct 16, 2025. Kyle Grillot | Bloomberg | Getty Images DETROIT — Sales of all-electric vehicles collapsed last month following the end of up to $7,500 in federal incentives for purchasing an EV, several automakers said Monday. Ford Motor, […]

Read More